Remote monitoring technologies offer a vital option for people with diabetes to manage their conditions, with tech developed ...

A report by GlobalData revealed that the biotech industry witnessed a 70.9% increase in total venture financing deal value.

Roche’s CEO Thomas Schinecker said the drugmaker is continuing talks with the US government over drug pricing reforms, as ...

Early-stage equity raises for biotechs surged by 71% in Q3 2025, hinting that the funding freeze that has gripped the ...

Alkermes has agreed to acquire Avadel Pharmaceuticals for up to $20 per share in cash, valuing Avadel at $2.1bn. The ...

Immunotherapy drugs continue to gain momentum across a growing range of disease areas with blockbusters such as Merck’s ...